CDXS · Codexis, Inc.
$1.45
+0.02 (+1.40%)
At close · Aug 5
Market Cap
$131.35M
Shares
90.90M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-27 | 2026-07-23 | |
| 8-K | 2026-07-23 | — | |
| 8-K | 2026-06-22 | 2026-06-17 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-28 | 2026-06-17 | |
| 8-K | 2026-04-14 | 2026-04-08 | |
| 8-K | 2026-03-11 | — | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | 2025-11-05 | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-06-11 | 2025-06-10 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-04-24 | 2025-06-10 | |
| 8-K | 2025-04-09 | 2025-04-04 | |
| 8-K | 2025-03-31 | 2025-03-28 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-16 | 2025-01-14 | |
| 8-K | 2024-11-12 | 2024-11-07 | |
| 8-K | 2024-10-31 | — | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-22 | 2024-10-16 | |
| 8-K | 2024-10-02 | 2024-09-30 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-13 | 2024-06-11 | |
| 8-K | 2024-05-14 | — | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | 2024-06-11 | |
| 8-K | 2024-03-06 | 2024-02-29 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-16 | 2024-02-13 | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2024-02-09 | 2024-02-08 | |
| 8-K | 2024-01-09 | — | |
| 8-K | 2023-12-27 | — | |
| 8-K/A | 2023-11-03 | 2023-07-20 | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-09-22 | 2023-09-21 | |
| 8-K | 2023-09-07 | 2023-09-01 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-20 | — |
Showing 1–50 of 106 filings
Key facts
CIK
1200375
CUSIP
192005106
13F (30d)
33 filings
32 filers
Visit website
Investor relations